UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000006497
Receipt No. R000007605
Scientific Title A phase II trial of sequential treatment from cisplatin-etoposide therapy (PE) to irinotecan hydrochloride + amrubicin hydrochloride therapy with concomitant use of G-CSF nartograstim in patients with extensive-stage small cell lung cancer or advanced large cell neuroendocrine carcinoma (LCNEC)
Date of disclosure of the study information 2011/10/07
Last modified on 2011/10/05 21:04:02

No. Disposal Last modified on Item of update
1 Insert 2011/10/06 20:40:37


Contact us.